According to a recent LinkedIn post from Oshi Health, the company is being highlighted as a partner of One GI, a large network of independent gastroenterology practices. The post centers on Oshi Health’s Access+ program, which is described as enabling One GI practices to expand clinical capacity, see more patients faster, and provide multidisciplinary support across the care journey.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The LinkedIn content also references Digestive Disease Week as a venue where Oshi representatives are available to discuss how the collaboration may reduce wait times and improve patient outcomes. For investors, the partnership suggests potential for increased patient volume flowing through Oshi’s virtual or hybrid care model, which could support revenue growth, strengthen payer and provider relationships, and enhance the company’s competitive positioning in gastroenterology-focused digital health.
The emphasis on capacity expansion and practice efficiency implies Oshi Health is positioning itself as an infrastructure-like solution for GI groups rather than just a niche telehealth service. If this model scales across additional groups beyond One GI, it could increase Oshi’s leverage in contract negotiations and improve unit economics, while also signaling market validation within a specialized but sizable segment of the healthcare services market.